Abstract
References
Dubrey SW, Cha K, Anderson J, et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 1998;91(2):141-57. Available from: https://doi.org/10.1093/qjmed/91.2.141
Merlini G, Palladni G. Amyloidosis: is a cure possible? Ann Oncol 2008;19(Suppl 4):iv63-iv66 Available from: https://doi.org/10.1093/annonc/mdn200.
Gertz MA, Lacy MQ, Dispenzieri A, Hayman, SR. Amyloidosis: diagnosis and management. Clin Lymphoma Myeloma. 2005;6:208-19. Available from: https://doi.org/10.3816/CLM.2005.n.048.
Available from: http://bestpractice.bmj.com/bestpractice/monograph/444/basics/pathophysiology.html
Fuster V, O’Rourke R, Walsh R, et al. Hurst’s The Heart. 12th ed. McGraw-Hill Professional. 2007
Lindholm PF, Wick MR. Isolated cardiac amyloidosis associated with sudden death. Arch Pathol Lab Med 1986;110:243-57.
Kyle RA. Amyloidosis. Circulation 1995;91:1269-71
Bhupathi SS, Chalasani S, Rokey R. Stiff heart syndrome. Clin Med Res 2011;9(2):92-9. Available from: https://doi.org/10.3121/cmr.2010.899
Rajkumar SV. Diagnosis of immunoglobulin light chain (AL) amyloidosis. Available from: www.uptodate.com
Falk RH. Cardiac amyloidosis: a treatable disease, often overlooked. Circulation 2011;124(9):1079-85. Available from: https://doi.org/10.1161/CIRCULATIONAHA.110.010447
Halwani O, Delgado DH. Cardiac amyloidosis: an approach to diagnosis and management. Expert Rev Cardiovasc Ther 2010;8(7):1007-13. Available from: https://doi.org/10.1586/erc.10.41
Grogan M, Gertz M, Kyle RA, Tajik AJ. Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol 200;85:664-5. Available from: https://doi.org/10.1016/s0002-9149(99)00832-2